Biotech Volatile Stocks; Biota Pharmaceuticals Inc (NASDAQ:BOTA), Alder Biopharmaceuticals Inc (NASDAQ:ALDR), Osiris Therapeutics (NASDAQ:OSIR), Insys Therapeutics Inc (NASDAQ:INSY)

Biota Pharmaceuticals Inc (NASDAQ:BOTA) said it plans to cut its workforce by about two-thirds and shut down its Melbourne, Australia, facility, following the loss of a key government contract. Biota Pharmaceuticals Inc (NASDAQ:BOTA) net profit margin is -10.50% and weekly performance is 1.34%. On last trading day company shares ended up $3.03. Analysts mean target price for the company is $5.00. Biota Pharmaceuticals Inc (NASDAQ:BOTA) distance from 50-day simple moving average (SMA50) is -6.83%.

On June 27, 2014, Alder Biopharmaceuticals Inc (NASDAQ:ALDR) announced that Alder will be added to the Russell 3000(R) Index at the close of the market today, Friday, June 27, 2014 when Russell Investments reconstitutes its set of U.S. and global equity indexes. Alder Biopharmaceuticals Inc (NASDAQ:ALDR) ended the last trading day at $18.10. Company weekly volatility is calculated as 8.55% and price to cash ratio as 43.22. Alder Biopharmaceuticals Inc (NASDAQ:ALDR) showed a positive weekly performance of 2.72%.

Osiris Therapeutics, Inc. (NASDAQ:OSIR), announced that the manuscript from its multi-center (n=20), randomized, controlled clinical trial comparing the safety and effectiveness of Grafix® to control in patients with chronic diabetic foot ulcers (DFUs) has been accepted for publication in the International Wound Journal. Osiris Therapeutics, Inc. (NASDAQ:OSIR) shares surged 3.92% in last trading session and ended the day on $16.69. OSIR Gross Margin is 74.60% and its return on assets is 16.60%. Osiris Therapeutics, Inc. (NASDAQ:OSIR) quarterly performance is 25.77%.

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Arizona on behalf of investors who purchased Insys Therapeutics Inc (NASDAQ:INSY) securities between May 1, 2013 and May 8, 2014. Insys Therapeutics Inc (NASDAQ:INSY) shares moved down -2.36% in last trading session and was closed at $31.44, while trading in range of $31.27 – $33.65. Insys Therapeutics Inc (NASDAQ:INSY) year to date (YTD) performance is 21.81%.